Literature DB >> 6109848

Labetalol and lipids.

R J McGonigle, L Williams, M J Murphy, V Parsons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109848     DOI: 10.1016/s0140-6736(81)90759-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Refractory hypertension: patient types, special problems, and approaches to therapy.

Authors:  J D Wallin
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

2.  Risk factors in the management of the unique hypertensive patient.

Authors:  J T Wright
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

Review 3.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 4.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

5.  Propranolol versus labetalol: interesting differences in efficacy.

Authors:  W Flamenbaum
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

Review 6.  Serum lipoproteins during treatment with antihypertensive drugs.

Authors:  P Weidmann; C Ferrier; H Saxenhofer; D E Uehlinger; B N Trost
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Adrenergic mechanisms in control of plasma lipid concentrations.

Authors:  J L Day; J Metcalfe; C N Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-17

Review 8.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Beta-blocker induced changes in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease.

Authors:  B G Woodcock; N Rietbrock
Journal:  Klin Wochenschr       Date:  1984-09-17

10.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.